Tag: Medicare Part D
Administration rolls out Medicare drug negotiations
August 30, 2023HME News Staff
WASHINGTON – The Department of Health and Human services has announced the first 10 medicines under Medicare Part D that have been selected under the Medicare Drug Price Negotiation Program.
They are: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp and Novolog insulin products.
These drugs accounted for $50.5 billion in total Part D gross covered prescription drug costs, or about 20%, of total Part D gross covered prescription drug costs...
